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Chirally pure (R)-1,3-butanediol ((R)-1,3-BDO) is a valuable intermediate for the
production of fragrances, pheromones, insecticides and antibiotics. Biotechnological
production results in superior enantiomeric excess over chemical production and is
therefore the preferred production route. In this study (R)-1,3-BDO was produced in
the industrially important whole cell biocatalyst Clostridium saccharoperbutylacetonicum
through expression of the enantio-specific phaB gene from Cupriavidus necator. The
heterologous pathway was optimised in three ways: at the transcriptional level choosing
strongly expressed promoters and comparing plasmid borne with chromosomal gene
expression, at the translational level by optimising the codon usage of the gene to fit
the inherent codon adaptation index of C. saccharoperbutylacetonicum, and at the
enzyme level by introducing point mutations which led to increased enzymatic activity.
The resulting whole cell catalyst produced up to 20 mM (1.8 g/l) (R)-1,3-BDO in non-
optimised batch fermentation which is a promising starting position for economical
production of this chiral chemical.
Keywords: Clostridium saccharoperbutylacetonicum, biotechnology, phaB, Allele Coupled Exchange, (R)-1,3-
butanediol, Clostridium
INTRODUCTION
Chirally active compounds are much sought after by the chemical and pharmaceutical industry. The
R-form of 1,3-butanediol (1,3-BDO), for example, is used for fragrances, pheromones, insecticides
and as starting material for the production of azetidinone derivatives. The latter are intermediates
of penem and carbapenem antibiotic synthesis (Nakatsuka et al., 1991; Matsuyama et al., 2001),
a major area of development. Old β-lactam antibiotics lose their efficacy against bacteria due to
emergent resistances which makes new discoveries crucial (Llarrull et al., 2010; Qin et al., 2014).
This makes the cost-effective production of precursor molecules an important field of study.
Chemical production of (R)-1,3-BDO from threonine via asymmetric hydrogenation of 4-
hydroxy-2-butanone (4H2B) has been studied, but satisfactory enantiomeric purity was not
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achieved (Larchevêque et al., 1991; Boaz et al., 2006). Enzymatic
production of (R)-1,3-BDO has the potential to be cheaper than
chemical production from petroleum-based substrates and its
stereo-specificity is superior with up to 100% of the product yield
having the desired conformation. Different whole cell catalysis
approaches have been adopted with mixed results. Reduction
through yeast fermentation of 4H2B led to low product yields
when the desired stereo-specificity was reached (Matsuyama
et al., 2001). However, later research showed promising results
when reducing 4H2B using either newly isolated yeast strains,
with up to 100% enantiomeric excess and a titre of 38.2 g/l (Zheng
et al., 2012; Yang et al., 2014), or genetically engineered E. coli,
where a 99% enantiomeric excess and 99% substrate yield were
obtained (Itoh et al., 2007). Another approach using genetically
modified E. coli based on the enantio-selective oxidation of (S)-
1,3-BDO was initially promising (Matsuyama et al., 2001) but
proved difficult to scale-up (Yamamoto et al., 2002).
As all of the above studies were reliant on relatively
expensive substrates, the use of cheaper alternatives would
benefit process economics. Two notable alternative routes
to (R)-1,3-BDO have been explored. Nemr et al. (2018)
assembled an elaborate metabolic pathway in E. coli that
mediated the condensation of two pyruvate-derived molecules
of acetaldehyde to form (R)-3-hydroxybutyrate ((R)-3-HB)
and further to (R)-1,3-BDO. (R)-1,3-BDO yield equivalent
to 13% of the theoretical maximum from glucose was
achieved. In another approach, Kataoka et al. (2013) designed
a synthetic pathway in E. coli encoding the acetyl-CoA
acetyltransferase (phaA) and the acetoacetyl-CoA reductase
(phaB) derived from Cupriavidus necator, combined with the
Clostridium saccharoperbutylacetonicum-derived butyraldehyde
dehydrogenase (bld) to produce 100.4 mM (9.05 g/l) (R)-1,3-
BDO with 98.5% enantiomeric excess in batch fermentation.
Fed-batch operation subsequently increased the product titre to
174.8 mM (15.8 g/l) (Kataoka et al., 2014).
C. saccharoperbutylacetonicum DSM 14923 (Hongo et al.,
1968) is a widely used industrial acetone-butanol-ethanol- (ABE-
) fermenting organism which is renowned for its particularly
high n-butanol yields (Shaheen et al., 2000; Herman et al.,
2017) and industrially favourable low sporulation capability (Keis
et al., 2001). It has been found to grow on a wide range
of industrially relevant first- and second-generation feedstocks,
such as glucose, cellobiose, xylose, arabinose, mannose, galactose,
pentose, starch and molasses (Shaheen et al., 2000; Yoshida
et al., 2012; Yao et al., 2017). These characteristics make
C. saccharoperbutylacetonicum an optimal whole cell biocatalyst
for industrial applications. Since C. saccharoperbutylacetonicum
possesses the necessary alcohol dehydrogenases and an inherently
strong acetyl-CoA acetyltransferase (thl), introduction of the
enantioselective PhaB from C. necator should be sufficient to
produce (R)-1,3-BDO in this organism, obviating the need
for multiple engineering steps. Green et al. (2017) expressed
a phaB gene codon optimised for generic Clostridium spp.
in C. saccharoperbutylacetonicum and observed 0.25 mM
of (R)-1,3-BDO (plasmid expression) and 6 mM (R)-1,3-
BDO (chromosomal integration) with no production of (S)-
1,3-BDO. This study improves on earlier work engineering
C. saccharoperbutylacetonicum for production of chirally pure
(R)-1,3-BDO, through optimisation of PhaB-mediated catalysis
at transcriptional, translational, enzyme and population levels.
MATERIALS AND METHODS
Bacterial Strains, Growth, and
Maintenance Conditions
E. coli HB101 (NEB, United Kingdom) was used as a
host strain for plasmid propagation. E. coli was grown at
30◦C or 37◦C in Luria-Bertani (LB) broth or on LB-agar
with 500 µg/ml erythromycin or 100 µg/ml spectinomycin.
Unless stated otherwise, all chemicals were purchased from
Sigma Aldrich, United Kingdom. The parent wild type
strain C. saccharoperbutylacetonicum N1-4 (HMT) DSM14923
(Hongo et al., 1968) was purchased from the German
collection of microorganisms and cell cultures GMBH (DSMZ).
All C. saccharoperbutylacetonicum strains were grown in an
anaerobic cabinet (Don Whitley, Yorkshire, United Kingdom) or
tent (Coy Lab Products, United States) with artificial atmosphere
(80:10:10 volume% nitrogen: carbon dioxide: hydrogen) at 37◦C
on solid RCM agar or on solid CBM (O’Brien and Morris,
1971). Standard liquid cultures were grown unshaken in TYA
(Tashiro et al., 2004) with, per litre in g: yeast extract, 2;
tryptone, 6; ammonium acetate, 3; MgSO4.7H2O, 0.3; KH2PO4,
0.5; FeSO4.7H2O, 0.01. Growth and solvent production assays
of C. saccharoperbutylacetonicum were performed in CGM,
2xYTG, CBM, P2 and Biebl medium, with the following
compositions per litre in g: CGM was prepared as described by
Hartmanis and Gatenbeck with some modification (Hartmanis
and Gatenbeck, 1984) yeast extract, 5; KH2PO4, 0.75; K2HPO4,
0.75; MgSO4.7H2O, 0.4; MnSO4.H2O, 0.01; FeSO4.7H2O, 0.01;
NaCl, 1; asparagine, 2; (NH4)2SO4, 2; glucose, 50; CaCO3,
20. 2xYTG contained: yeast ectract, 10; tryptone, 16; NaCl,
5. CBM similar to O’Brien and Morris (1971), MgSO4.7H2O,
0.2; MnSO4.H2O, 0.00758; FeSO4.7H2O, 0.01; p-aminobenzoic
acid, 0.001; biotin, 2 × 10−6; thiamine HCl, 0.001; casein
hydrolysate, 4; K2HPO4, 0.5; KH2PO4, 0.5 (O’Brien and Morris,
1971). P2 similar to Baer et al. (1987), K2HPO4, 0.5; KH2PO4,
0.5; ammonium acetate, 2.2; MgSO4.7H2O, 2; MnSO4.H2O, 0.1;
NaCl, 0.1; FeSO4.7H2O, 0.1; p-aminobenzoic acid, 0.1; thiamine,
0.1; biotine, 0.01 (Baer et al., 1987). Biebl media composition
similar to Biebl, 2001: KH2PO4, 0.5; K2HPO4, 0.5; (NH4)2SO4,
5; MgSO4.7H2O, 0.2; CaCl2.2H2O, 0.02; FeSO4.7H2O, 0.00914;
biotin, 25 × 10−6; 2 ml trace element solution made up
of, per litre in mg: MnCl2.4H2O, 100; ZnCl2, 70; H3BO3,
60; NaMoO4.2H2O, 40; CoCl2.6H2O, 28.7; CuCl2.2H2O, 20;
NiCl2.6H2O, 20; 1 ml 25% HCl (Biebl, 2001). All media were
prepared with 50 g/l glucose and 20 g/l CaCO3 and adjusted to
pH 6.2. For antibiotic selection in C. saccharoperbutylacetonicum,
cultures were supplemented with 50 µg/ml erythromycin or
250 µg/ml spectinomycin.
Growth curves were done by growing
C. saccharoperbutylacetonicum strains until mid-exponential
phase for inoculation of triplicate 35 ml CGM broths to an
OD600 of 0.05 in 250 ml serum bottles. The bottles were capped
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with rubber-butyl stoppers inside a cabinet and transferred
outside the cabinet for crimping and static incubation at
37◦C. Glucose, acids and solvents including (R)-3-HB and
(R)-1,3-BDO were quantified with HPLC as previously described
(Schwarz et al., 2017). Data was analysed with Graphpad
PRISM 8.1 (Graphpad Software Inc., United States). The
chirality of 3-HB and 1,3-BDO is determined using LC/MS
analysis following DATAN (Diacetyl-L-Tartaric Anhydride)




Electro-competent Clostridium cells were prepared based on the
method described by Little et al. (2018). Culture in exponential
phase was used to inoculate 300 ml TYA to OD600 0.05 and grown
to mid-exponential phase (OD600 0.4–0.6). Cells were centrifuged
at 7,500 rpm for 10 min and washed twice with ice-cold, reduced
EPB buffer (270 mM Sucrose, 5 mM Na2HPO4, 5 mM NaH2PO4,
pH 7.4), resuspended in 9 ml ice-cold EPB buffer containing
10% dimethyl sulphoxide and aliquots frozen at −80◦C. For
electroporation 580 µl of competent cells and typically 6 µg
plasmid were added to a 4 mm electroporation cuvette inside an
anaerobic cabinet. The mixture was kept on ice for 5 min before
being electroporated with pulse settings of 2 kV, 25 µF and∞.
Cells were immediately mixed with 10 ml warm TYA to recover
for 6 h. Finally, cells were plated out on appropriate medium with
appropriate antibiotics for selection.
Plasmid Stability Assay
Plasmid segregational stability was determined as
described previously (Heap et al., 2009). Briefly,
C. saccharoperbutylacetonicum transformants were cultured
for 12 h in TYA medium supplemented with the antibiotic
erythromycin to select for the plasmid. The culture was washed
twice in PBS to remove the antibiotic and then used to inoculate
fresh, unsupplemented TYA medium at 1% (vol/vol). This
marked the start (i.e., 0 h) of the stability experiment. The
unsupplemented culture was then diluted 1% (vol/vol) into fresh
medium every 12 h. At 12, 24, 36, 48, 60, 72, 84, and 96 h the
culture was plated on both selective and non-selective agar to
enumerate erythromycin-resistant colony-forming units and
total colony-forming units.
Plasmid Cloning
All restriction enzymes used were fast digest enzymes
(ThermoFisher Scientific, United Kingdom), the ligase
used throughout this work was the Rapid DNA Ligation
Kit (ThermoFisher Scientific, United Kingdom). Plasmids
were transformed into chemically competent E. coli HB101
according to supplier’s instructions (New England Biolabs,
United Kingdom). Plasmids are listed in Supplementary




Plasmid pMTL83353::phaB (p_phaB) was cloned by digesting
pMTL83251-pfdx_PhaB (Green et al., 2017) (featuring the phaB
gene from C. necator N-1 codon optimised for Clostridium
spp.) and pMTL83353 (Heap et al., 2009) with NdeI and NheI,
ligating the fragment containing phaB into the pMTL83353
backbone. The point-mutated p_phaB derivatives were produced
using the Quikchange site-directed mutagenesis kit according to
supplier’s instruction (Agilent, United Kingdom) using primers
Q47L_F and Q47L_R to produce pMTL83353::phaB_Q47L
(p_phaB_L) and primers T173S_F and T173_R to produce
pMTL83353::phaB_T173S (p_phaB_S). To produce the plasmid
pMTL83353::phaB_Q47L_T173S (p_phaB_LS) carrying the phaB
double-mutant, plasmid p_phaB_L was point-mutated using the
Quikchange site directed mutagenesis kit as above with primers
T173S_F and T173S_R.
The C. necator phaB gene was codon optimised to match
the C. saccharoperbutylacetonicum codon adaptation index
using the codon usage table calculated by Nakamura et al. at
https://www.kazusa.or.jp/codon/(accessed 3/9/2019) (Nakamura
et al., 2000). The codon optimised phaB fragment (phaB-
opt) and the point mutated derivatives phaB-opt_Q47L,
phaB-opt_T173S and phaB-opt_Q47L_T173S were ordered as
synthetic DNA fragments (Twist Bioscience, United States)
flanked by NotI and NdeI restriction sites upstream of the
gene and HindIII and NheI downstream of the gene. The
fragments were cloned into pMTL83353 (Heap et al., 2009)
by digesting the plasmid and the fragments with NdeI and
NheI and ligating each fragment separately into the digested




The Allele Coupled Exchange (ACE) (Heap et al., 2012) pyrE
truncation plasmid pMTL-AGH21 (p_AGH21) was cloned by
amplifying the following with Phusion High-Fidelity DNA
Polymerase (New England Biolabs, United Kingdom): (i)
a 300 bp fragment of the DSM14923 pyrE gene with
primers pE_upstream_F and SOE_pE_trunc_up_R; (ii) the
282 bp multiple cloning site (MCS) from pMTL-ME6C
(Heap et al., 2012)with primers SOE_pE_trunc_up_F and
SOE_pE_trunc_dwn_R; (iii) the 1,200 bp downstream region of
the DSM14923 pyrE locus with primers SOE_pE_trunc_dwn_F
and pE_downstream_R. All three fragments were spliced
together by splicing by overlap extension PCR (SOE-PCR) with
primers pE_upstream_F and pE_downstream_R for ligation into
pMTL85241 (Heap et al., 2009) at Sbf I and AscI sites.
The cargo delivery ACE plasmid pMTL-AGH23 (p_AGH23)
was cloned by amplifying the following: (i) a 626 bp fragment
of pyrE with primers pE_upstream_F and SOE_pE_KI_up_R; (ii)
a 323 bp fragment of the MCS from pMTL-ME6C (Heap et al.,
2012) with primers SOE_pE_KI_up_F and SOE_pE_KI_dwn_R;
(iii) a 1,200 bp fragment downstream of the DSM14923 pyrE
locus with primers SOE_pE_KI_dwn_F and pE_downstream_R.
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The three fragments were used in a SOE-PCR as above
with primers pE_upstream_F and pE_downstream_R, for
ligation into pMTL85241.
Plasmid pMTL-AGH23::cspo_fdx-phaB was cloned by
digesting p_phaB and p_AGH23 with enzymes NotI and
NheI and ligating the resulting phaB fragment into the
p_AGH23 backbone. The same process led to production
of pMTL-AGH23::cspo_fdx-phaB-opt using plasmids
p_AGH23 and p_phaB-opt and pMTL-AGH23::cspo_fdx-phaB-
opt_Q47L_T173S using p_AGH23 and p_phaB-opt_LS. Plasmids
pMTL-AGH23::cac_ptb-phaB-opt and pMTL-AGH23::cac_ptb-
phaB-opt_Q47L_T173S were produced by exchanging the
promoter Pcspo_fdx with promoter Pcac_ptb from plasmid
pMTL8225::cac_ptb_gusA (p_ptb-gusA) through digestion of
pMTL-AGH23::cspo_fdx-phaB or pMTL-AGH23::cac_ptb-
phaB-opt and p_ptb-gusA with NotI and NdeI cloning the
Pcac_ptb promoter into the 5,215 bp backbone.
gusA Reporter Plasmids
Reporter plasmids to measure promoter strength were
cloned fusing promoters from a promoter library (Willson,
2014) with a gusA (β-glucuronidase) gene. The latter
was based on plasmid pMTL-JL1 (pMTL8514::fdx-
gusA) which consisted of the Streptococcus agalactiae
gusA gene (Wallace et al., 2015) under control of the
C. acetobutylicum ferredoxin gene promoter in the modular
shuttle vector pMTL85141. Plasmids pMTL8225::cac_araE-gusA
(p_araE-gusA), pMTL8225::cac_adhE-gusA (p_adhE-gusA),
pMTL8225::cac_ptb-gusA (p_ptb-gusA) and pMTL8225::
pj23119-gusA (p_pj-gusA) were constructed by digesting both
pMTL8514::fdx-gusA and pMTL82251 (Heap et al., 2009) with
NotI and NheI and ligating the fdx-gusA fragment into the





pMTL8225::ccv_thl-gusA (p_ccv_thl-gusA) and pMTL8225::
cby_thl-gusA (p_cby_thl-gusA) were cloned by digesting the
corresponding pMTL82254 based plasmids (Willson, 2014;
Supplementary Table 1) and p_ptb-gusA with enzymes NotI
and NdeI and cloning the [promoter] fragment excised from
pMTL82254::[promoter] into the backbone of p_ptb-gusA. The
same process led to production of pMTL8225::cspo_fdx-gusA
(p_cspo_fdx-gusA) by digestion of pMTL83353 (Heap et al.,
2009) and p_ptb-gusA with NotI and NdeI and ligating the
cspo_fdx fragment into the backbone.
Allelic Exchange Mutant Generation
C. saccharoperbutylacetonicum1pyrE truncation and gene
insertions downstream of pyrE were made as described by Heap
et al. (2012). C. saccharoperbutylacetonicum DSM14923 was
transformed with plasmid p_AGH21 followed by selection on
RCM plates containing erythromycin. Faster growing colonies
(potential single crossover integrants) were restreaked three times
on CBM agar supplemented with 400 µg/ml 5-fluoroorotic acid
and 20 µg/ml uracil and tested by colony PCR and subsequent
Sanger sequencing (Eurofins Genomics, United Kingdom)
for pyrE truncation and absence of plasmid. Colony PCR
was performed as previously described for Clostridium
pasteurianum (Pyne et al., 2013) with primers pE_genome_F
and pE_genome_R. PCR products were sequenced with primer
ACE_insert_seq_F. Plasmid loss was confirmed by colony PCR
with primers 85XXX-RF and 8X2XX-RR.
Cargo integrated strains C. saccharoperbutylacetonicum 
Cspo_fdx-phaB (fdx-phaB), Cspo_fdx-phaB-opt (fdx-
phaB-opt), Cac_ptb-phaB-opt (ptb-phaB-opt), Cspo_
fdx-phaB-opt_Q47L_T173S (fdx-phaB-opt_LS) and Cac_ptb-
phaB-opt_Q47L_T173S (ptb-phaB-opt_LS) were produced
by transforming the corresponding pMTL-AGH23 cargo
plasmid into C. saccharoperbutylacetonicum1pyrE followed
by direct selection for double-crossover integration on CBM
plates without uracil. Integration was tested by PCR with
primers pE_genome_F and pE_genome_R leading to a 2,836 bp
fragment for fdx-phaB, a 2,892 bp fragment for both Pcspo_fdx
promoter based gene insertions and a 2,895 bp fragment for both
Pcac_ptb promoter-based insertions if integration was successful,
compared to 2,213 bp in C. saccharoperbutylacetonicum1pyrE.
PCR products were sequenced with primers ACE_insert_seq_F
and ACE_insert_seq_R. Plasmid loss was confirmed by PCR with
primers 85XXX-RF and 8X2XX-RR.
GusA Reporter Assay
Promoter strength in C. saccharoperbutylacetonicum was tested
by measuring GusA activity when gusA was expressed from
different promoters according to protocols by Miller (1972). Cell
pellets from 1 ml cultures were defrosted and resuspended in
up to 500 µl of Z-buffer (60 mM Na2HPO4, 45 mM NaH2PO4,
10 mM KCl, 1 mM MgSO2.7H2O, 50 mM β-mercaptoethanol, pH
8.5) to normalise OD600 across all samples. A 75 µl volume of the
sample was transferred to a Corning 96 Well Black Polystyrene
Microplate with clear bottom (Merck, United Kingdom) and
OD600 measured in a Clariostar Plus plate reader (BMG Labtech,
United Kingdom). Reaction was started by addition of 25 µl
of 40 µg/ml 4-methylumbelliferyl-β-D-glucuronide dissolved in
Z-buffer to each sample. Fluorescence was measured for 30 min at
450 nm after excitation at 360 nm at a distance of 7 mm and with
a gain of 750. The resulting data was analysed in Excel (Microsoft
Corporation, United States) by measuring slope of the regression
line in the linear phase and the data was further analysed in
GraphPad PRISM 8.1 (GraphPad Software Inc., United States).
RESULTS
Based on previous studies in E. coli (Kataoka et al.,
2013), a pathway to chirally pure (R)-1,3-BDO in
C. saccharoperbutylacetonicum was formulated based on
the conversion of acetoacetyl-CoA to (R)-3-hydroxybutyryl-CoA
using the C. necator enzyme acetoacetyl-CoA reductase encoded
by phaB. In E. coli the condensation of two acetyl-CoA to
one acetoacetyl-CoA was reliant on the over-expression of
the C. necator phaA gene (coding for 3-ketothiolase). This
was not necessary in C. saccharoperbutylacetonicum since the
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FIGURE 1 | The natural acid- and solvent- producing pathways of C. saccharoperbutylacetonicum and the heterologous pathway from acetoacetyl-CoA via PhaB
(acetoacetyl-CoA reductase, 22). Numbers correspond to enzymes as follows: 1, hexokinase; 2, phosphoglucose isomerase; 3, phosphofructokinase; 4,
glyceraldehyde-3-phosphate dehydrogenase; 5, pyruvate kinase; 6, lactate dehydrogenase; 7, pyruvate-ferredoxin oxidoreductase; 8, phosphate acetyltransferase;
9, acetate kinase; 10, acetaldehyde dehydrogenase; 11, ethanol dehydrogenase; 12, thiolase; 13, acetoacetyl-CoA:acetate:CoA
transferase/acetoacetyl-CoA:butyrate:CoA transferase; 14, acetoacetate decarboxylase; 15, β-hydroxybutyryl-CoA dehydrogenase; 16, crotonase; 17, butyryl-CoA
dehydrogenase; 18, phosphotransbutyrylase; 19, butyrate kinase; 20, butyraldehyde dehydrogenase; 21, butanol dehydrogenase; 22, acetoacetyl-CoA reductase
(phaB, from Cupriavidus necator).
endogenous thiolase gene (thlA) is highly expressed (Wiesenborn
et al., 1988). Furthermore, the endogenous enzymes alcohol-
and aldehyde-alcohol dehydrogenases (bdh and adh) should
catalyse the reactions from (R)-3-hydroxybutyryl-CoA via (R)-3-
hydroxybutyraldehyde to (R)-1,3-BDO analogous to reduction
of butyryl-CoA to butanol (Figure 1). The side product (R)-
3-HB was expected to be produced predominantly through
conversion of (R)-3-hydroxybutyryl-CoA via the endogenous
phosphotransbutyrylase (ptb) to (R)-3-hydroxybutyryl-P and
further via butyrate kinase (buk) to (R)-3-HB in analogy to the
natural conversion of butyryl-CoA to butyrate. Additionally,
some (R)-3-HB maybe produced by unspecific hydrolysis of the
CoA thioester bond by endogenous thioesterases analogous to
E. coli (Guevara-Martínez et al., 2019).
Growth and Solvent Production
Various growth media were tested for solvent production from
C. saccharoperbutylacetonicum DSM 14923 with the expectation
that media supporting high solvent production would also
promote (R)-1,3-BDO production (Supplementary Figure 1).
The strain produced the highest yield of solvents per glucose (g
solvents/g glucose) when grown in complex media (CGM and
TYA) with 0.28 ± 0.02 g/g and 0.28 ± 0.00 g/g, respectively. In
minimal Biebl medium the strain still produced 0.24 ± 0.00 g/g
solvents. The highest solvent to acid ratio was found when
growing on minimal media P2 or Biebl with 4.4 g/g (g solvents/g
acids) and 4.3 g/g, respectively, while the ratio was 3.2 g/g
for CGM and 3.5 g/g for TYA. However, since PhaB uses the
four-carbon intermediate acetoacetyl-CoA to produce (R)-3-
hydroxybutyryl-CoA, the 4-carbon to 2-carbon product ratio is
more important for the production of (R)-1,3-BDO. This ratio
was 5.1 g/g (g 4-carbon products/g 2-carbon products) for CGM,
3.5 g/g for TYA, 3.9 g/g for P2 and 5.0 g/g for Biebl medium.
Thus, as it was expected that the highest yields of (R)-1,3-BDO
yield in C. saccharoperbutylacetonicum strain would be obtained
when grown in CGM, this medium was used throughout the
rest of this work.
Plasmid Stability Assays
Four Gram-positive replicons (Heap et al., 2009) were tested
for segregational stability in C. saccharoperbutylacetonicum by
following the ratio of antibiotic resistant (plasmid containing)
cells to total cell counts in non-selective media over time. The two
most stable replicons were pBP1 and pCB102 over 8 generations
which corresponded to approximately 96 h (Figure 2). Due
to its reduced length of 1,625 bp compared to 2,403 bp of
pBP1, the second most stable replicon pCB102 was chosen for
plasmid-based expression of the heterologous phaB gene, as
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FIGURE 2 | Plasmid stability assay testing four Gram-positive replicons in C. saccharoperbutylacetonicum. Plasmid pMTL82251 with pBP1 replicon in red circles,
pMTL83251 with pCB102 replicon in blue squares, pMTL84251 with pCD6 replicon in green upward pointing triangles and pMTL85251 with pIM13 replicon in
downward pointing triangles.
increasing plasmid size has been shown to negatively correlate
with transformation efficiency (Hanahan, 1983).
Plasmid Borne Expression of phaB With
Increased Catalytic Activity
Production of (R)-1,3-BDO was measured in
C. saccharoperbutylacetonicum cells containing the plasmid
p_phaB expressing the C. necator phaB (coding for acetoacetyl-
CoA reductase) gene under the control of the promoter of
the Clostridium sporogenes fdx gene (Pcspo_fdx) (Figure 3, also
Supplementary Figure 2). A control strain carrying the empty
vector pMTL83353 was included for comparative purposes.
Expression of phaB slowed growth of the strain considerably and
the highest cell density was reached only after 48 h as compared
to 24 h in the control. Strain p_phaB produced 6.3 ± 0.1 mM
of (R)-1,3-BDO after 48 h while the control did not produce
the compound, establishing that the pathway was functioning
as intended. The by-product (R)-3-HB was produced at up
to 5.1 ± 0.1 mM and is assumed to be reassimilated in the
solventogenic phase via acetoacetate-CoA transferase (ctfAB)
as it is the case for butyrate and acetate. The chemical chirality
of 1,3-BDO and 3-HB were confirmed to be enantio-specific R
form in previous study (Green et al., 2017). No S form of either
compounds was found in the fermentation broth.
Point mutations Q47L and T173S in PhaB have previously
been shown to increase activity and poly-3-HB accumulation
in Corynebacterium glutamicum (Matsumoto et al., 2013) and
in tobacco (Yokoo et al., 2015). Both point mutations were
introduced separately into PhaB (plasmids p_phaB_L and
p_phaB_S) and a double mutant (plasmid p_phaB_LS) was
produced. C. saccharoperbutylacetonicum cells carrying plasmids
p_phaB_L, p_phaB_S and p_phaB_LS produced 10.2 ± 0.2,
7.8 ± 0.1 and 10.3 ± 0.1 mM (R)-1,3-BDO, respectively
(Figure 3).
Codon Optimisation of Plasmid
Expressed Enzyme
The second option chosen to increase product titres after the
point mutations, was to translationally optimise the heterologous
C. necator gene through the alteration of its codon frequency
to match that of C. saccharoperbutylacetonicum. Codon usage
frequencies were determined using the database compiled by
Nakamura and coworkers (Nakamura et al., 2000). Synonymous
substitutions were made selecting codons with the highest
frequency of usage in C. saccharoperbutylacetonicum. The
resulting gene (phaB-opt), single point mutations (phaB-opt_L
& phaB-opt_S) and the double point mutated gene (phaB-
opt_LS) were ordered as synthetic constructs. Fermentation
performance of the strains carrying codon optimised genes was
tested against a plasmid control (Figure 4 and Supplementary
Figure 3). Plasmids p_phaB-opt (6.3 ± 0.7 mM) and p_phaB-
opt_S (8.8 ± 0.4 mM) produced slightly higher (R)-1,3-BDO
concentrations while p_phaB-opt_L (8 ± 0.2 mM) and p_phaB-
opt_LS (9.2 ± 0.3 mM) produced slightly less compared to the
p_phaB based constructs.
GusA Promoter Strength Assays
Although several native Clostridium and synthetic
promoters have been used for enzyme expression in
C. saccharoperbutylacetonicum (Nakayama et al., 2008;
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FIGURE 3 | Comparison of product spectrum of Cupriavidus necator wild type phaB and the derivatives with point mutations and negative control without phaB
(p_83353) expressed in C. saccharoperbutylacetonicum after 48 h. From left to right for each product p_83353 in black, p_phaB in red, p_phaB_L in green,
p_phaB_S in blue, p_phaB_LS in purple. For glucose the consumed amount is shown for all other the produced amount. Error-bars represent SEM and * represents
statistical significance against p_phaB (t-test, p < 0.05), n = 3.
FIGURE 4 | Comparison of product spectrum C. saccharoperbutylacetonicum cells carrying the empty plasmid control p_83353 and codon optimised phaB and its
derivatives with point mutations after 48 h. From left to right for each product p_83353 in chequerboard, p_phaB_opt in red diagonal lines, p_phaB-opt_L in green
bricks, p_phaB-opt_S in purple squares and p_phaB-opt_LS in green dots. Error-bars represent SEM.
Zhang et al., 2018) no systematic analysis of promoter
strength has been published in this organism so far. A gusA
(β-glucuronidase) reporter gene was employed to assess the
relative strength of various clostridial promoters, including a
library derived from the fdx and thl genes of several different
clostridial species (Willson, 2014) as well as a synthetic
promoter (iGEM part BBa_J23119). The gusA gene derived from
Streptococcus agalactiae DSM 2134 was chosen because of its
compatible GC content and codon usage as well as favourable
kinetic properties of the encoded enzyme (Wallace et al., 2015),
which were similar to those of E. coli GusA previously employed
in C. acetobutylicum (Girbal et al., 2003). Relative promoter
strength at 24 h post-inoculation was measured and the resulting
gusA activities cluster into weak, mid-strength and strong
promoters (Figure 5). Although the C. sporogenes fdx promoter
(Pcspo_fdx) is known to be a strong promoter for expression of
heterologous genes in Clostridium owing to its central position
in the ABE-fermentation pathway (Minton et al., 2016), it was
ineffective in C. saccharoperbutylacetonicum. The strongest
promoter identified was that of the C. acetobutylicum ptb gene
(Pcac_ptb) which was nearly 5400-fold stronger than Pcspo_fdx.
Since the phosphotransbutyrylase (ptb) in Clostridium is only
strongly expressed during exponential (acidogenic) phase in
C. acetobutylicum (Girbal et al., 2003) and Clostridium beijerinckii
(Ravagnani et al., 2000), GusA activity with expression from
Pcac_ptb and Pcspo_fdxpromoters in C. saccharoperbutylacetonicum
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FIGURE 5 | Promoter assay based on GusA production measured by accumulation of fluorescent product. A library of promoters derived from fdx and thl genes as
well as a library of C. acetobutylicum promoters were tested for expression strength in C. saccharoperbutylacetonicum. Expression profiles over time of the
strongest promoter Pcac_ptb and the standard promoter Pcspo_f dx were further assayed (inset graph). Error-bars represent SEM with n = 6 for all samples in the bar
chart except p_82251 and Pcspo_f dx (n = 3) and n = 3 for all samples in the inset diagram.
FIGURE 6 | Comparison of product spectrum of the codon optimised phaB version and its derivatives encoding PhaB point mutations expressed in
C. saccharoperbutylacetonicum by either weak promoter Pcspo_f dx or strong promoter Pcac_ptb from the chromosomal pyrE locus after 48 h. From left to right for
each product DSM14923 in black, fdx-phaB-opt in red horizontal lines, ptb-phaB-opt in burgundy horizontal lines, fdx-phaB-opt_LS in light purple diagonal
lines and ptb-phaB-opt_LS in purple horizontal lines. Error-bars represent SEM (n = 3).
was measured over 48 h (Figure 5). The activity of Pcac_ptb was
high over the whole time-course, whilst gusA expression from
the Pcspo_fdx promoter was only marginally higher than that of
the empty vector control pMTL82251.
phaB Chromosomally Integrated at the
pyrE Locus
The C. necator phaB gene was integrated into the
C. saccharoperbutylacetonicum chromosome downstream of
the pyrE gene using the ACE method (Heap et al., 2012).
Selection for reversion to uracil prototrophy by restoration of the
pyrE gene was used as a marker for successful cargo integration.
A 3-fold higher (R)-1,3-BDO concentration of 19 ± 0.7 mM
was produced after 48 h when phaB was expressed from the
chromosome (cspo_fdx-phaB) (Figure 6), than when expressed
on a plasmid (p_phaB). A two-fold increase in product titre was
obtained compared to the best performing plasmid-based codon
optimised mutant (p_phaB-opt_LS).
Production of (R)-1,3-BDO by chromosomal expression of
codon optimised phaB (phaB-opt) and the codon optimised
double mutant (phaB-opt_LS) were measured from the
differing strength Pcac_ptb and Pcspo_fdx promoters. All the
codon optimised genes produced increased (R)-1,3-BDO
concentrations compared to the p_phaB sequence. The
weak Pcspo_fdx promoter (fdx-phaB-opt: 20 ± 0.1 mM;
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fdx-phaB-opt_LS: 18 ± 1.6 mM) performed marginally
better than the strong Pcac_ptb promoter (ptb-phaB-opt
17.3± 1.1 mM; ptb-phaB-opt_LS 17.6± 0.3 mM) (Figure 6).
DISCUSSION
Different growth conditions were tested for maximal solvent
production in C. saccharoperbutylacetonicum and a stable
plasmid selected for expression of heterologous phaB. Having
shown that expression of phaB leads to (R)-1,3-BDO production
in C. saccharoperbutylacetonicum, options to increase the
production titre were analysed. Three possibilities on different
levels of protein expression were considered. Firstly, at an enzyme
level, the catalytic activity of PhaB can be increased through point
mutations in sites which were identified previously (Matsumoto
et al., 2013). Secondly, translational efficiency can be increased
by codon optimisation of the gene to match it to the natural
codon adaptation of C. saccharoperbutylacetonicum (Quax et al.,
2015). And lastly, increasing mRNA levels through boosting of
transcription efficiency can be achieved through the use of strong
promoters (Deuschle et al., 1986).
Point Mutations in phaB Result in a Small
Increase of (R)-1,3-BDO Production
Matsumoto et al. (2013) engineered and tested a library of
approximately 20,000 phaB mutants generated by error prone
PCR of which two variant genes were isolated that encoded
an enzyme that exhibited increased kcat values compared to
the wild type enzyme. In one mutant a glutamine at position
47 was changed to leucine (Q47L) and in the other mutant
a threonine at position 173 was changed to serine (T173S).
Both mutated enzymes showed increased activity and poly-3-
hydroxybutyrate accumulation when heterologously expressed
in Corynebacterium glutamicum (Matsumoto et al., 2013) and
in tobacco (Yokoo et al., 2015). It was hypothesised that
introduction of these point mutations in phaB and expression in
C. saccharoperbutylacetonicum should analogously lead to higher
metabolic flux toward (R)-1,3-BDO. Both point mutations were
introduced separately and a double mutant carrying both amino
acid changes was created. Both single mutants exhibited the
desired effect of increased (R)-1,3-BDO, however, the double
mutant did not show an accumulative titre increase (Figure 3).
PhaB Q47L mutant (p_phaB_L) produced the highest amount
of (R)-1,3-BDO, 1.6-fold higher than the PhaB wild type,
while the T173S mutant (p_phaB_S) only showed a 1.2-fold
increase of product titre. The double mutant produced the
same amount as p_phaB_L which suggested either product
inhibition at this level or the fact that the mutations cannot
function in conjunction. Product inhibition can be ruled out
by a growth assay in increasing meso-1,3-BDO concentrations
which found C. saccharoperbutylacetonicum to grow uninhibited
up to 300 mM of meso-1,3-BDO (Supplementary Figure 4).
On the other hand, the fact that the effects of the two
mutations would not accumulate could be explained based on
data collected by Matsumoto et al. (2013). They found that
PhaB T173S increases kcat/Km(Acetoacetate−CoA) and decreases
kcat/Km(NADPH) while PhaB Q47L enhances kcat/Km(NADPH) and
decreases kcat/Km(Acetoacetate−CoA). Therefore, the positive effects
on catalytic enzyme activity of each mutation could cancel the
effect of the other.
It was interesting to note that both p_phaB and p_phaB_S
had a detrimental effect on C. saccharoperbutylacetonicum
growth, evident by a slower growth rate and longer fermentation
time (Supplementary Figure 2). Both strains also used less
glucose than the control. This effect was reversed in p_phaB_L
and p_phaB_LS. Suggesting that the Q47L mutation offsets
the deleterious effect of phaB expression while increasing
product formation. The deleterious effects of phaB on
C. saccharoperbutylacetonicum growth were not observed
in any of the codon optimised versions of the gene analysed
(Supplementary Figures 3, 6). Since the only difference between
the native phaB and phaB_L are two nucleotides (138-CAG
and 130-CTG, respectively) and the same two nucleotides were
altered to 138-CAA in phaB-opt (Supplementary Figure 5) it can
be assumed that the deleterious effect stems from translational
complications in this region. Correddu et al. (2019) found that
co-occurrence of certain amino acid codons in E. coli led to
a premature stop in the protein chain potentially through a
frameshift. Similar effects could be at play here. The codon
adaptation frequency pattern found in the vicinity of the
mutation, however, does not suggest codon rarity to be a factor
(Supplementary Figure 5), since the point mutated version uses
an uncommon (in C. saccharoperbutylacetonicum) CTG codon
for lysine (Nakamura et al., 2000). Thus, the ultimate cause of the
observed deleterious effect cannot be ascertained.
Codon Optimisation of phaB Has
Minimal Impact on Product
Concentration
Although codon optimisation was expected to lead to higher
product yield, this was not found to be the case here (Figure 4).
This was not entirely unexpected as codon optimisation based on
the codon adaption index of an organism is relatively random
with no significant correlation between the use of frequent
codons and protein expression (Kudla et al., 2009). Future work
should include codon harmonisation, where the relative native
codon frequency per codon location found in C. necator is
synchronised in the heterologous host organism. This approach
takes into consideration mRNA regions presenting codons with
low relative frequency (or codon adaptation index, CAI) which
are hypothesised to slow down translation and allowing correct
folding of the protein (Quax et al., 2015). Furthermore, it was
shown that the 5’ mRNA leading sequence has a big influence
on protein expression and surprisingly it was found that these
sequences are preferably made up of rare codons, allowing
appropriate ribosome distribution on the coding mRNA (Kudla
et al., 2009; Quax et al., 2015).
Chromosomal Integration Significantly
Increases (R)-1,3-BDO Formation
Concomitant with testing the influence of codon optimisation
on product titres the consequence of locating the heterologous
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phaB to the host chromosome as opposed to an autonomous
plasmid was evaluated. Stable chromosomal integration is key to
biotechnological exploitation of this technology by abolishing the
need for antibiotics in fermentation and overcoming the inherent
instability of replicative plasmids (Friehs, 2004; Heap et al., 2012).
Expression was expected to be lower when the gene was expressed
from the chromosome since there are more copies of the plasmid
present than of the chromosome. This higher copy number would
hypothetically translate into more mRNA and subsequently
more protein, which in turn should be reflected in increased
product titres. However, 3-fold higher (R)-1,3-BDO production
was found in the mutant expressing phaB from the chromosome
(cspo_fdx-phaB) compared with it being expressed from a
plasmid (p_phaB) and double the product titres compared to
the best performing plasmid-based codon optimised mutant
(p_phaB-opt_LS) were found (Figure 7). This effect was also
previously reported by our team member (Green et al., 2017).
This finding suggests that overexpression of phaB has
a negative impact on the final product titres. This may
be due to pathway overloading, protein aggregation or
polymerisation, liquid phase separation or general resource
exhaustion of the cell (Bolognesi and Lehner, 2018). If any of
these overexpression related issues play a role, then further
overexpression would be pointless. To test this hypothesis
phaB and the double mutant (phaB_LS) and codon optimised
versions were expressed from the chromosome under the
strong Pcac_ptb promoter and tested against expression from
the weak Pcspo_fdx promoter (fdx-phaB-opt). Product titres
for (R)-1,3-BDO were lower when phaB-opt was strongly
overexpressed with Pcac_ptb (ptb-phaB-opt) or when the
potentially more active double mutant was used (fdx-phaB-
opt_LS and ptb-phaB-opt_LS). However, one-way ANOVA
revealed that the reduction was not significant [F(3,7) = 0.71,
p = 0.57].
FIGURE 7 | 1,3-butanediol production from all the different constructs tested in this study. Error-bars represent SEM (n = 3).
TABLE 1 | Summary of literature to date presenting microbial production of (R)-1,3-BDO from different substrates.
Highest titre of
(R)-1,3-BDO [g/l]
Organism Substrate Notes References
49.5 E. coli JM109 4-Hydroxy-2-butanone with
2-propanol as co-substrate










Optimised preparative scale bioconversion process Yang et al., 2014
15.6 E. coli MG1655
lacIq




9.05 E. coli MG1655
lacIq
Glucose Plasmid borne overexpression of phaA and phaB from Ralstonia
eutropha NBRC 102504 and bldfrom




2.4 E. coli BL21 Glucose Plasmid borne expression of pyruvate decarboxylase (Zymomonas
mobilis) and the deoxyribose-5-phosphate aldolase (Bacillus
halodurans) in two stage pH controlled bioreactor fermentation
Nemr et al., 2018
1.1 E. coli
LMSE51C
Glucose Aerobic pH controlled fed-batch fermentation of strain from Nemr
et al. (2018) with BH1352 harbouring mutations F160Y/M173I
Kim et al., 2020
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These findings suggest that the earlier hypothesis was correct
and more active or higher expressed phaB does not lead to
increased product titres. Since not only overexpression but also
increasing enzyme activity by introduction of point mutations
led to decreased product titre (fdx-phaB-opt compared to
fdx-phaB-opt_LS), protein burden on the cell (Eguchi et al.,
2018), protein underwrapping (Birchler and Veitia, 2012) or
protein aggregation (Rosano and Ceccarelli, 2014) as a cause
can potentially be excluded. Instead, evidence points toward
reactant or product inhibition of the reaction. It is not clear
through what mechanism this inhibition arises. However, the
unfamiliar R stereo form of the substrates (R)-3-hydroxybutyryl-
CoA and (R)-3-hydroxybutyraldehyde may not be reduced
efficiently by native enzymes butyraldehyde dehydrogenase and
butanol dehydrogenase, leading to intracellular build up that may
cause feedback inhibition. Moreover, similar effects have been
reported before and were attributed to metabolic imbalances
caused by highly overexpressed genes and high enzyme activity
of heterologously expressed genes (Atsumi et al., 2008; Kataoka
et al., 2013).
Final Remarks
It was shown that (R)-1,3-BDO can be produced up to
20 mM (1.8 g/l) in a non-optimised batch fermentation with
C. saccharoperbutylacetonicum. This is the first time (R)-1,3-BDO
production from glucose has been shown outside of E. coli in
an anaerobic non-optimised batch fermentation. Titres reached
are similar to studies using plasmid borne expression of pyruvate
decarboxylase from Zymomonas mobilis and deoxyribose-5-
phosphate aldolase from Bacillus halodurans (Nemr et al., 2018;
Kim et al., 2020) but lower than in studies using plasmid borne
expression of PhaA and PhaB from R. eutropha coupled with
expression of Bld from C. saccharoperbutylacetonicum (Kataoka
et al., 2013, 2014) summarised in Table 1. Higher titres can be
reached using 4-hydroxy-2-butanone as substrate (Itoh et al.,
2007; Zheng et al., 2012; Yang et al., 2014), however glucose
is more widely available and more ecenomical than 4-hydroxy-
2-butanone. Finally, future work should aim at optimising the
fermentation and at upscaling of the production which is easier
with an anaerobic organism such as the one used in this work.
Here, three non-exclusive approaches to increase
production of (R)-1,3-BDO were tested and combined.
Firstly, point mutations were applied to increase enzyme
activity. Secondly, the gene was codon optimised to fit the
C. saccharoperbutylacetonicum codon adaptation index. Lastly,
the point-mutated and codon-optimised versions of phaB
were expressed from the chromosome with differing strength
promoters. However, it has been shown that increasing
transcription and protein activity did not lead to increased
product titres. On the contrary these alterations led to decreased
product formation by unknown mechanisms. Future work
should aim at investigating these imbalances, debottlenecking
the downstream pathway (e.g., by overexpression of endogenous
genes of the pathway) and optimising the fermentation to
increase product titres further.
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